Many people first learned about mRNA vaccines during the coronavirus pandemic, when the companies Pfizer-BioNTech and Moderna released their COVID-19 vaccines. The Pfizer-BioNTech shot was the first ...

Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he's pulling the plug on nearly $500 million in funding for the development of mRNA vaccines. Here's how they work.

People are still debating whether the mRNA from COVID-19 vaccines remains in the body longer than it should. Some say it ...

The federal government is cutting $500 million in research money for development of mRNA vaccines, which were widely used against the COVID-19 virus. Health Secretary Robert F. Kennedy Jr. said in a ...

In the fast-evolving field of medical science, a new artificial intelligence model may be about to change the way mRNA-based drugs and vaccines are designed. Developed through a collaboration between ...

Russia's EnteroMix vaccine, based on mRNA tech, showed 100% efficacy in early cancer trials. Designed to shrink tumours and ...

Scientists developed a groundbreaking class of mRNA medicines that can sense changes in the body and autonomously adjust their therapeutic effect. The new mRNA medicine works by responding to specific ...

Clinical studies suggest these vaccines can generate immunological memory, allowing lymphocytes to respond to tumor ...

While mRNA changed the game in vaccines, leveraging the technology to develop treatments has been trickier to navigate.

When you buy through links on our articles, Future and its syndication partners may earn a commission. MRNA technology was thrust into the limelight during the COVID-19 pandemic, but had been in ...